Suneena Pokkamthanam
Physician Assistant · Bakersfield, CANPI 1396163945
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 357 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,741 and has fallen 77.8% since, to $830 in 2025. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 357 payments — averaging $21.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$1K
- Sunovion Pharmaceuticals Inc.$840
- Alkermes, Inc.$675
- Otsuka America Pharmaceutical, Inc.$584
- Lundbeck LLC$570
- plus $3K from 16 others
What the payments were for
- Food & beverage$7,79299%
- Education$521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 38 | $1,136 |
| AbbVie | 53 | $1,004 |
| Sunovion Pharmaceuticals Inc. | 42 | $840 |
| Alkermes, Inc. | 26 | $675 |
| Otsuka America Pharmaceutical, Inc. | 27 | $584 |
| Lundbeck LLC | 30 | $570 |
| Neurocrine Biosciences, Inc. | 21 | $493 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $492 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $455 |
| Teva Pharmaceuticals USA, Inc. | 23 | $417 |
| Neuronetics, Inc. | 1 | $232 |
| E.r. Squibb & Sons, L.L.C. | 6 | $202 |
| Livanova USA, Inc. | 10 | $200 |
| Noven Therapeutics, LLC | 7 | $161 |
| Supernus Pharmaceuticals, Inc. | 7 | $132 |
| Vanda Pharmaceuticals Inc. | 5 | $106 |
| Indivior Inc. | 2 | $49 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $17 |
| Neos Therapeutics, LP | 1 | $16 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$472
- INVEGA SUSTENNA$245
- NEUROSTAR TMS THERAPY$232
- VRAYLAR$125
- COBENFY$124
- INGREZZA$124
- INVEGA TRINZA$120
- ARISTADA INITIO$118
- REXULTI$101
How this compares
$7,844 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 27 | $25,704 |
| Duloxetine Hcl | 41 | $1,888 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 38 | $1,772 |
| Aripiprazole | 47 | $1,385 |
| Ziprasidone Hcl | 11 | $1,111 |
| Trazodone Hcl | 90 | $1,081 |
| Quetiapine Fumarate | 120 | $1,078 |
| Vilazodone Hcl | 15 | $986 |
| Escitalopram Oxalate | 112 | $832 |
| Bupropion XlBupropion Hcl | 80 | $819 |
| Atomoxetine Hcl | 13 | $810 |
| Paroxetine Hcl | 13 | $809 |
| Mirtazapine | 63 | $708 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 41 | $691 |
| Risperidone | 44 | $639 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $584 | $25,70427 claims |
| Almatica Pharma LLCSertraline Hcl | $14 | $410106 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Bakersfield
- Anita GarrettBakersfield$41K
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Andrea FoxStanford$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.